ANASTRAVAC 1

ANASTRAVAC 1 contains Anastrozole, a potent aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. By inhibiting the aromatase enzyme, it reduces estrogen production, which helps slow or stop the growth of estrogen-dependent cancer cells.

Key Features:

• Effective in hormone receptor-positive breast cancer therapy

• Reduces estrogen levels to control tumor growth

• Once-daily oral dosing for convenience

• Suitable for adjuvant treatment or advanced breast cancer